Atlantis Glory (AGLY) Current Deferred Revenue (2018 - 2019)
Atlantis Glory (AGLY) posted Current Deferred Revenue of $4.5 million for Q3 2019, up 204.03% sequentially from $1.5 million in Q4 2018.
Atlantis Glory (AGLY) Current Deferred Revenue (2018 - 2019) Analysis & Trends
Atlantis Glory has reported Current Deferred Revenue for 2 years, with the latest figure at $4.5 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - |
| 10 | Atlantis Glory | 12.08 Mn | 12.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 4.47 Mn |
| Dec 31, 2018 | 1.47 Mn |